These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 23213275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).
    Sajovic J, Cilenšek I, Mankoč S, Tajnšek Š, Kunej T, Petrovič D, Globočnik Petrovič M.
    Bosn J Basic Med Sci; 2019 Feb 12; 19(1):94-100. PubMed ID: 30579324
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
    Abu El-Asrar AM, Mohammad G, Allegaert E, Ahmad A, Siddiquei MM, Alam K, Gikandi PW, De Hertogh G, Opdenakker G.
    Mol Vis; 2018 Feb 12; 24():394-406. PubMed ID: 29853773
    [Abstract] [Full Text] [Related]

  • 4. The relationships between type 2 diabetic retinopathy and VEGF-634G/C and VEGF-460C/T polymorphisms in Han Chinese subjects.
    Yuan Y, Wen Z, Guan Y, Sun Y, Yang J, Fan X, Yang X, Liu R.
    J Diabetes Complications; 2014 Feb 12; 28(6):785-90. PubMed ID: 25217793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.
    Beránek M, Kanková K, Benes P, Izakovicová-Hollá L, Znojil V, Hájek D, Vlková E, Vácha J.
    Am J Med Genet; 2002 May 15; 109(4):278-83. PubMed ID: 11992481
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of NF-κB activation and VEGF gene polymorphisms in VEGF up regulation in non-proliferative and proliferative diabetic retinopathy.
    Choudhuri S, Chowdhury IH, Das S, Dutta D, Saha A, Sarkar R, Mandal LK, Mukherjee S, Bhattacharya B.
    Mol Cell Biochem; 2015 Jul 15; 405(1-2):265-79. PubMed ID: 25956512
    [Abstract] [Full Text] [Related]

  • 9. An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy.
    Szaflik JP, Wysocki T, Kowalski M, Majsterek I, Borucka AI, Blasiak J, Szaflik J.
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan 15; 246(1):39-43. PubMed ID: 17849138
    [Abstract] [Full Text] [Related]

  • 10. Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes.
    Feghhi M, Nikzamir A, Esteghamati A, Mahmoudi T, Yekaninejad MS.
    Transl Res; 2011 Aug 15; 158(2):85-91. PubMed ID: 21757152
    [Abstract] [Full Text] [Related]

  • 11. Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.
    Petrovic MG, Korosec P, Kosnik M, Osredkar J, Hawlina M, Peterlin B, Petrovic D.
    Mol Vis; 2008 Jul 30; 14():1382-7. PubMed ID: 18682813
    [Abstract] [Full Text] [Related]

  • 12. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes.
    Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P.
    Diabetes; 2004 Mar 30; 53(3):861-4. PubMed ID: 14988276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. VEGF polymorphisms are associated with severity of diabetic retinopathy.
    Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PE, Ray DW.
    Invest Ophthalmol Vis Sci; 2008 Aug 30; 49(8):3611-6. PubMed ID: 18441306
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of tumor necrosis factor α, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects.
    Paine SK, Sen A, Choudhuri S, Mondal LK, Chowdhury IH, Basu A, Mukherjee A, Bhattacharya B.
    Retina; 2012 Jun 30; 32(6):1197-203. PubMed ID: 22105495
    [Abstract] [Full Text] [Related]

  • 17. Association of vascular endothelial growth factor a gene (VEGFA) polymorphisms, rs699947 and rs1570360, with diabetic retinopathy and altered VEGF secretion in the Pakistani patients with type 2 diabetes mellitus: a casecontrol study.
    Qayyum S, Afzal M, Naveed AK, Butt IA, Sajjad M, Azam M.
    J Pak Med Assoc; 2023 Dec 30; 73(12):2348-2356. PubMed ID: 38083911
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N, Xu H, Yu N, Wu Y, Yu L.
    Clin Exp Pharmacol Physiol; 2020 Jan 30; 47(1):85-94. PubMed ID: 31408201
    [Abstract] [Full Text] [Related]

  • 20. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy.
    Nakamura S, Iwasaki N, Funatsu H, Kitano S, Iwamoto Y.
    Graefes Arch Clin Exp Ophthalmol; 2009 Jan 30; 247(1):21-6. PubMed ID: 18709380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.